Skip to main content
logo
Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.6498
-0.0182 (-2.72%)
At close: Mar 6, 2026, 4:00 PM EST
0.6103
-0.0395 (-6.09%)
After-hours: Mar 6, 2026, 5:39 PM EST

Cellyan Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Market Cap
712--
Market Cap Growth
-63.29%---
Enterprise Value
6.510.3800
Last Close Price
0.651.08--
PE Ratio
--360.00--
PS Ratio
0.350.58--
PB Ratio
1.472.38--
P/TBV Ratio
1.352.24--
P/FCF Ratio
14.2823.79--
P/OCF Ratio
12.5320.87--
EV/Sales Ratio
0.320.51--
EV/EBITDA Ratio
24.430.28--
EV/EBIT Ratio
34.160.29--
EV/FCF Ratio
13.0220.80--
Debt / Equity Ratio
0.300.300.300.46
Debt / EBITDA Ratio
0.060.060.070.03
Debt / FCF Ratio
4.764.76-4.670.43
Net Debt / Equity Ratio
-0.13-0.130.340.28
Net Debt / EBITDA Ratio
-0.02-0.020.050.01
Net Debt / FCF Ratio
-1.26-1.26-3.260.10
Asset Turnover
2.162.252.763.69
Inventory Turnover
31.9623.9723.3651.43
Quick Ratio
2.802.801.771.00
Current Ratio
2.992.992.461.08
Return on Equity (ROE)
-0.54%-0.59%54.96%170.56%
Return on Assets (ROA)
-285.85%-297.70%402.25%593.55%
Return on Invested Capital (ROIC)
-586.53%-480.13%610.38%1516.82%
Return on Capital Employed (ROCE)
552.76%599.28%878.07%2413.69%
Earnings Yield
-0.38%-0.28%--
FCF Yield
7.00%4.20%--
Buyback Yield / Dilution
-36.20%-36.20%--
Updated Mar 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q